Polymeric prodrugs of the formula: ##STR1##

wherein

    • B is selected from the group consisting of OH, leaving groups, residues of amine-containing moieties and a residues of hydroxyl-containing moieties;
    • Y1 is selected from the group consisting of O, S, and NR5;
    • M is NR3, O or S;
    • Ar is a moiety which when included in Formula I forms a multi-substituted aromatic or heteroaromatic hydrocarbon or a multi-substituted heterocyclic group;
    • (m) is zero or a positive integer;
    • R1-3 and R5 are independently selected from the group consisting of hydrogen, C1-6 alkyls, C3-12 branched alkyls, C3-8 cycloalkyls, C1-6 substituted alkyls, C3-8 substituted cycloalkyls, aryls, substituted aryls, aralkyls, C1-6 heteroalkyls, substituted C1-6 heteroalkyls, C1-6 alkoxy, phenoxy and C1-6 heteroalkoxy; and
    • R4 is a polymeric residue;

      as well as methods of making and using the same are disclosed.

  •  
    Web www.patentalert.com

    < Method of down-regulating gene expression

    < Adenosine derivatives and use thereof

    > Biocatalyst inhibitors

    > Method for purifying protected 2-deoxycytidines and hydrated crystals thereof

    ~ 00204